UK markets closed

Bio-Gate AG (BIG1.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.88000.0000 (0.00%)
At close: 05:20PM CEST

Bio-Gate AG

Neumeyerstrasse 28-34
Nuremberg 90411
Germany
49 9 11 47 75 23
https://www.bio-gate.de

Sector(s)Healthcare
IndustryMedical Instruments & Supplies
Full-time employees

Key executives

NameTitlePayExercisedYear born
Mr. Marc Lloret-GrauChairman of the Management Board, CEO & MDN/AN/AN/A
Thomas KonradtChief Business Development Officer, Head of Business Development & Member of Executive BoardN/AN/AN/A
Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

Bio-Gate AG provides technologies and customized solutions for health and hygiene in Germany. The company offers HyProtect, a plasma coating, which protects the surfaces of medical implants against bacterial colonization. It also provides MicroSilver BG elemental microporous silver additives. The company's products are used in large and medium-sized medical technology companies, pharmaceutical distributors, distribution companies, industrial companies, public sector companies, and hygiene-sensitive institutions. The company was founded in 2005 and is based in Nuremberg, Germany.

Corporate governance

Bio-Gate AG’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.